Cero Therapeutics Holdings (CERO) Change in Accured Expenses (2022 - 2026)
Cero Therapeutics Holdings (CERO) posted Change in Accured Expenses of -$15,779 for Q2 2026, compared with -$104,599 a year earlier.
Powered by 
Analysis
Cero Therapeutics Holdings (CERO) Change in Accured Expenses (2022 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Change in Accured Expenses at Cero Therapeutics Holdings was $119,949, down 87.3% year-over-year; for FY2025, it came in at -$405,538.
- In prior years, Cero Therapeutics Holdings' Change in Accured Expenses was $2.34 million in FY2024 (+24.5%), $1.88 million in FY2023 (+14.8%), $1.64 million in FY2022 and $80,324 in FY2021.
- Quarterly Change in Accured Expenses has run from a low of -$299,690 in Q1 2025 to a high of $1.13 million in Q2 2023 over five years.
- The strongest year-over-year quarter for Change in Accured Expenses in the past five years was Q4 2024, with growth of 264.2%; the weakest was Q4 2025, with a decline of 97.2%.
- According to Business Quant data, Change in Accured Expenses for the three prior quarters was $136,977 (Q1 2026), $23,120 (Q4 2025) and -$24,369 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,144.36 Bn | 1,112.95 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 635.36 Bn | 555.22 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 502.79 Bn | 475.90 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 356.08 Bn | 310.46 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 300.87 Bn | 264.86 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 264.31 Bn | 237.99 Bn | 12.86 Bn | - |
| 7 | Amgen | 239.07 Bn | 194.47 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 194.50 Bn | 168.70 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 171.00 Bn | 117.64 Bn | 10.94 Bn | - |
| 10 | Cero Therapeutics Holdings | 638,128.24 | -4.84 Mn | - | -15,779.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -15,779.00 |
| Mar 31, 2026 | 136,977.00 |
| Dec 31, 2025 | 23,120.00 |
| Sep 30, 2025 | -24,369.00 |
| Jun 30, 2025 | -104,599.00 |
| Mar 31, 2025 | -299,690.00 |
| Dec 31, 2024 | 815,772.00 |
| Sep 30, 2024 | 535,422.00 |
| Jun 30, 2024 | 849,417.00 |
| Mar 31, 2024 | 141,982.00 |
| Dec 31, 2023 | 223,986.00 |
| Sep 30, 2023 | 165,114.00 |
| Jun 30, 2023 | 1.13 Mn |
| Mar 31, 2023 | 364,064.00 |
| Dec 31, 2022 | 942,765.00 |
| Sep 30, 2022 | 547,352.00 |
| Jun 30, 2022 | 41,661.00 |
| Mar 31, 2022 | 106,909.00 |
API Access
Cero Therapeutics Holdings Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CERO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "CERO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CERO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();